RNU6-1073P

Across TCGA pan-cancer cohorts, RNU6-1073P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-1073P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-1073P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1073P expression acts as an unfavorable survival marker.

UCEC, TGCT, and LGG are the cancer types where RNU6-1073P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.505	0.840	.003	36	view →
TGCT	DFS	Tertile	All	0.014	0.837	<.001	18	view →
LGG	DFS	Tertile	All	0.224	0.728	.025	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU6-1073P–UCEC (DFS)

Open the UCEC breakdown →